Month: April 2025
Biotech
GLP
Industry
Pharmaceutical
Regulation
Understanding about the FDA’s Embrace of New Approach Methodologies
In a landmark decision signaling a paradigm shift in pharmaceutical safety assessment, the U.S. Food and Drug Administration (FDA) announced on April 10, 2025, a plan to phase out the requirement for animal testing in the...
Pharmaceutical
Sci&Tech
Why Nav1.8 inhibitor is non-addictive pain killer
Journavx (VX-548, Suzetrigine) was approved in 2025 as the only new non-opoid painkiller in the past two decades. As we know it is a Nav1.8 inibitor, here we explain why Nav1.8 inhibitors won’t cause addiction(Disclaimer: based on the...